NCT00552708View on ClinicalTrials.gov

A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.

PHASE1CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Hypertension

Interventions

DRUG

COREG CR

DRUG

Lisinopril

Trial Locations (1)

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00552708 - A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL. | Biotech Hunter | Biotech Hunter